Category: NOVAPREP®

Paris, France and Camberley, UK – 2 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised

Paris, France et Camberley, UK – 27 décembre 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce la finalisation de la cession de l’activité NOVAprep à Algimed Trade Ltd. (« Algimed ») pour un montant de 400 000 euros et 10% de royalties sur les ventes dans

Paris, France and Camberley, UK – 27 December 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it has completed the sale of NOVAprep® assets to Algimed Trade Ltd. (“Algimed”), for a total consideration of €400,000 and a 10% royalty on sales in certain defined territories. Algimed specialises in